Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MCD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Large-scale testing (Phase 3)UnknownNCT05234684
What this trial is testing

Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With MCD Subtype Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)
Beijing InnoCare Pharma Tech Co., Ltd. 150
Large-scale testing (Phase 3)Looking for participantsNCT07499700
What this trial is testing

A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis

Who this might be right for
Minimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS)
Bio-Thera Solutions 192
Testing effectiveness (Phase 2)Study completedNCT04009668
What this trial is testing

Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease

Who this might be right for
FSGSMCDFocal Segmental Glomerulosclerosis+1 more
University of Michigan 7
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Early research (Phase 1)Ended earlyNCT00071942
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Male Breast CancerRecurrent Breast CancerStage IV Breast Cancer
National Cancer Institute (NCI) 22
Not applicableStudy completedNCT07702981
What this trial is testing

Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome

Who this might be right for
Membranous NephropathyMinimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS)
University Hospital, Ioannina 40
Testing effectiveness (Phase 2)Looking for participantsNCT06500702
What this trial is testing

Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion
Sanofi 84
Large-scale testing (Phase 3)Not Yet RecruitingNCT06405100
What this trial is testing

Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD

Who this might be right for
Minimal Change Disease
Air Force Military Medical University, China 81
Not applicableUnknownNCT03101397
What this trial is testing

The Clinical Value of Serum KL-6 Changes on Evaluating Disease Development in Different Diffuse Parenchymal Lung Disease

Who this might be right for
Diffuse Parenchymal Lung Disease
The First Affiliated Hospital of Guangzhou Medical University 180
Large-scale testing (Phase 3)UnknownNCT00006250
What this trial is testing

Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Lymphoma Trials Office 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT03933904
What this trial is testing

Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease

Who this might be right for
Castleman DiseaseCastleman's Disease, Multicentric
University of Pennsylvania 7
Not applicableLooking for participantsNCT01209000
What this trial is testing

Nephrotic Syndrome Study Network

Who this might be right for
Minimal Change Disease (MCD)Membranous NephropathyGlomerulosclerosis, Focal Segmental
University of Michigan 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT06983028
What this trial is testing

Atacicept in Multiple Glomerular Diseases

Who this might be right for
pMNIgANNephrotic Syndrome+2 more
Vera Therapeutics, Inc. 250
Large-scale testing (Phase 3)Study completedNCT00981838
What this trial is testing

Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Nephrotic Syndrome
Mario Negri Institute for Pharmacological Research 24
Not applicableLooking for participantsNCT02817997
What this trial is testing

International Registry for Patients With Castleman Disease

Who this might be right for
Castleman DiseaseCastleman's DiseaseGiant Lymph Node Hyperplasia+6 more
University of Pennsylvania 1,000
Not applicableStudy completedNCT01451710
What this trial is testing

The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy

Who this might be right for
IgA Nephropathy
Nanjing University School of Medicine 30